Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other 1

Conditions

Endometrial Neoplasms 2Overweight 1Obesity 1Neoplasms 1Gliosarcoma 1Glioblastoma 1Endometrial Hyperplasia 1

Interventions

Paclitaxel 16pembrolizumab 12Carboplatin 11Specimen Handling 10Magnetic Resonance Spectroscopy 8Biopsy 7Taxes 5Fulvestrant 5Doxorubicin 5olaparib 4dostarlimab 4Nivolumab 4Gemcitabine 4Docetaxel 4Cisplatin 4Bevacizumab 4palbociclib 3X-Rays 3Oxaliplatin 3Leucovorin 3Fluorouracil 3trastuzumab deruxtecan 2ribociclib 2pertuzumab 2ipatasertib 2binimetinib 2abemaciclib 2Trastuzumab 2Surveys and Questionnaires 2Progestins 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Progestins × 30 days × Clear all
NCT05255653 2026-05-15

RAINBO

Leiden University Medical Center

Phase 2/3 Recruiting
1,615 enrolled
Gynecologic

Endometrial Neoplasms

NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡